From Pharmacological Informatics to Informational Pharmacology: A Conceptual Shift in Therapeutics
DOI:
https://doi.org/10.5281/zenodo.18719816Keywords:
information pharmacology; pharmacological informatics; digital therapeutics.Abstract
This article offers a conceptual analysis of AI within information pharmacology, exploring its role as both a supportive tool and an autonomous therapeutic factor. It distinguishes between pharmacological informatics (instrumental level) and information pharmacology (ontological level) and proposes criteria for classifying AI systems as information-based medicinal products, focusing on dose-dependent, reproducible, and clinically meaningful effects. The study examines the relationship between material (molecular) and informational therapeutics, highlighting their conceptual connections and ontological distinctions. Comparative analysis of pharmacodynamics and pharmacokinetics elucidates therapeutic windows, dosing, efficacy, and risk for information-based interventions. The role of formal models in standardization, prediction, and regulatory evaluation is discussed. Finally, legal and ethical considerations for digital medicine and increasingly autonomous therapeutic systems are addressed, emphasizing the emerging framework for safely integrating AI into clinical practice.
References
Beauchamp, T. L., & Childress, J. F. (2019). Principles of biomedical ethics (8th ed.). Oxford University Press.
Ekins, S. (2007). Computational toxicology: Risk assessment for pharmaceutical and environmental chemicals. John Wiley & Sons.
Hollis, C., Falconer, C. J., Martin, J. L., Whittington, C., Stockton, S., Glazebrook, C., & Davies, E. B. (2017). Digital health interventions for children and young people with mental health problems. Journal of Child Psychology and Psychiatry, 58(4), 474–503.
Lipsky, M. S., & Sharp, L. K. (2019). From idea to market: The emerging field of digital therapeutics. BMJ Innovations, 5(2), 60–63.
Meadows, D. H., Meadows, D. L., Randers, J., & Behrens, W. W., III. (1972). The limits to growth: A report for the Club of Rome’s project on the predicament of mankind. Universe Books.
Testa, B., & van de Waterbeemd, H. (2001). Pharmacokinetic optimization in drug research. Wiley-VCH.
Wishart, D. S. (2018). Computational approaches to drug discovery and development. Drug Discovery Today, 23(12), 1875–1886.
World Medical Association. (2013). World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA, 310(20), 2191–2194. https://doi.org/10.1001/jama.2013.281053
Downloads
Published
Issue
Section
License
Copyright (c) 2026 M. Ya. Golovenko, V. B. Larionov
This work is licensed under a Creative Commons Attribution 4.0 International License.